Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 60, Issue 1, 1999, Pages 21-29

  Cai, J ^a   Jiang, W G ^a   Mansel, R E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA LINOLENIC ACID;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0032939221     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1998.0004     Document Type: Article

References (41)

1. 1. Rastinejad F., Poverini P. J., Bouck N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppresser gene. Cell 1989; 56: 345-355.
2. 2. O'Reilly M. S., Holmgren L., Shing Y. et al. Angiostatin: a novel inhibitor that mediates the suppression of metastases by a Lewis lung carinoma. Cell 1994; 79: 315-328.
3. 3. Van Meir E. G. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 1994; 8: 171-176.
4. 4. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
5. 5. Hama Y., Shimizu T., Hosaka S., Sugenoya A., Usuda N. Therapeutic effecacy of the angiogenesis inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice. Exp Toxicol Pathol 1997; 49: 239-247.
6. 6. Taylor S., Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982; 297: 307-312.
7. 7. Frater-Schroder M., Risau W., Hallman R., Gautschi P., Bohlen P. Tumour necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro. Proc Natl Acad Sci USA 1987; 84: 5277-5281.
8. 8. Gately S., Twardowski P., Stack M. S. et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sce USA 1997, 94: 10868-10872.
9. 9. Gastl G., Hermann T., Steurer M., Zmija J., Gunsilius F., Unger C., Kraft A. Angioenesis as a target for tumour treatment. Oncol 1997; 54: 177-184.
10. 10. Folkman J. What is the evidence that tumours are tumour-dependent? J Natl Cancer Inst 1990; 82: 4-6.
11. 11. Maione T. E., Sharpe R. J. Development of angiogenesis inhibitors for clinical applications. Trends Pharmacol Sci 1990; 11:457-461.
12. 12. Denkamp J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993; 66: 181-196.
13. 13. Gottesman M. M. Report of a meeting: molecular basis of cancer therapy. J Natl Cancer Inst 1994; 86: 1277-1285.
14. 14. Karp J. E., Border S. Molecular foundations of cancer: new targets for intervention. Nat Med 1995; 1: 309-319.
15. 15. Ligo M., Nakagawa T., Ishikawa C. et al. Inhibitiory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 1998; 75: 650-655.
16. 16. Jiang W. G., Hiscox S., Bryce R. P., Horrobin D. F., Mansel R. E. The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. Br J Cancer 1998, 77: 731-738.
17. 17. Hawkins R. A., Sangster K., Arends M. J. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 1998; 185: 61-70.
18. 18. Tsai W. S., Nagawa H., KaiZaki S., Tsuruo T., Muto T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 1998; 33: 206-212.
19. 19. Solomon L. Z., Jennings A. M., Hayes M. C., Bass P. S., Birch B. R., Cooper A. J. Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies. Urol Res 1998; 26: 11-15.
20. 20. Horribin D. F. Essential fatty acids, lipid peroxidation, and cancer. In: Horribin D. F. (ed). Omega-6 essential fatty acids. New York: Wiley-Liss, 1990; 351-378.
21. 21. Jiang W. G., Hiscox S., Hallett M. B., Horribin D. F., Mensal R. E., Puntis M. C. A. Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 1995; 71: 744-752.
22. 22. Jiang W. G., Bryce R. P., Horrobin D. F. Essential fatty acids, the molecular and cellular mechanisms of their anticancer action and clinical implications. Crit Rev Oncol Haematol 1998; 27: 179-209.
23. 23. Ormerod L. D., Garsd A., Abelson M. B., Kenyon K. R. Effects of altering the eicosanoid precusor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Am J Pathol 1990; 137: 1243-1252.
24. 24. Verbey N. L. J., Van Haeringen N. J., de Jong P. T. V. M. Modulation of immunogenic keratin's in rabbits by topical administration of polyunsaturated fatty acids. Curr Eye Res 1988; 7: 549-556.
25. 25. Nicosia R. F., Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta: A quantitative assay of angiogenesis in vitro. Lab Invest 1990; 63: 115-122.
26. 26. Kanayasu T., Morita I., Nakao-Hayash J. et al. Eicosapentenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids 1991; 26(4): 271-276.
27. 27. Albrech-Buehler G. The phagokinetic tracks of 3T3 cells. Cell 1977; 11: 395-404
28. 28. Gimbrone M. A., Cotran R. S., Folkman J. Human vascular endothelial cells in culture. J Cell Biol 1974; 60: 673-684.
29. 29. Jiang W. G., Bryce R. P., Horrobin D. F., Mansel R. E. Gamma linolenic acid regulates gap junction communications in endothelial cells and their interaction with tumour cells. Prostagland Leuk Essent Fatty Acids 1997; 56(4): 307-316.
30. 30. Kumar R., Yoneda J., Bucana C. D., Fidler I. J. Regulation of distanct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998; 12: 749-757.
31. 31. Clifford S. C., Czapla K., Richards F. M., ODonoughue D. J., Maher E. R. Hepatocyte growth factor stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and VHL tumour-suppressor and related genes. Br J Cancer 1998; 77: 1420-1428.
32. 32. Nagy J., Curry G. W., Hillan K. J., Mallon E., Purushotham A. D., George W. D. Hepatocyte growth-factor scatter factor, angiogenesis and tumor-cell proliferation in primary breast-cancer. Breast 1996; 5(2): 105-109.
33. 33. Jiang W. G., Mensal R. E. Progress in anti-invasion and anti-metastasis research and treatment. Int J Oncol 1996; 9: 1013-1028.
34. 34. Camussi G., Montrucchio G., Lupia E., Soldi R., Comoglio P. M., Bussolino F. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol 1997; 158(3): 1302-1309.
35. 35. Lamszus K., Jin L., Fuchs A., Shi E. et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 1997; 76(3): 339-353.
36. 36. Laterra J., Nam M., Rosen E., Rao J. S., Lamszus K., Goldberg I. D., Johnston P. Scatter factor hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 1997; 76(4): 565-577.
37. 37. Jiang W. G., Hiscox S. Hepatocyte growth factor and c-met, a cytokine playing multiple and converse roles. Histol Histopathol 1997; 12: 537-555.
38. 38. Toh Y., Pencil S. D., Nicolson G. L. Analysis of the complete sequence of the novel metastasis associated candidate gene, mtal, differentially expressed in mammary adenocaricnoma and breast-cancer cell-lines. Gene 1995; 159: 97-104.
39. 39. Folkman J., Klagsbrun M. Angiogenic factor. Science 1987; 235: 442-447.
40. 40. Jahroudi N., Greenberger J. S. The role of endothelial cell in tumor invasion and metastasis. J Neurooncol 1995; 23: 99-108.
41. 41. Lampugnani M. G., Corada M., Andriopoulou P., Esser S., Risau W., Dejana E. Cell confluence regulates tyrosine phosphorylation of adherins junction components in endothelial cells. J Cell Sci 1997; 110: 2065-2077.